Meeting Coverage:

Duke Advanced Vitreous Surgery Courses

Duke AVS 2025

AI in Clinical Trials: Where We Are Now

Show Description +

Dr. Allingham asks Dr. Jaffe to discuss the role of AI in retina clinical trials and what the future might hold. For one, AI could save time and money when evaluating retinal imaging, according to Dr. Jaffe.

Posted: 5/28/2025

Up Next

Inducing a PVD in Young Patients

Xi Chen, MD, PhD; and Yuxi Zheng, MD


Tips for Scleral Fixated IOLs

Yannek I. Leiderman, MD, PhD; and Durga S. Borkar, MD, MMCi

RD Repair: Timing Matters

David Zacks, MD, PhD; and Dilraj Grewal, MD

Gene Therapy: Surgical Pearls

Avni P. Finn, MD, MBA; and Lejla Vajzovic, MD, FASRS

Imaging Adult Patients Born Premature

Aleksandra V. Rachitskaya, MD; and Cynthia Toth, MD

Managing PVR: Tips and Tricks

Jason Hsu, MD; and Sharon Fekrat, MD

GLP-1 Receptor Agonists and DR

Majda Hadziahmetovic, MD; and Oleg Alekseev, MD, PHD

Managing MTM and Macular Holes

Gavin Tan, MD, PhD, FRCSed; and Krish Kasetty, MD

Tracking Peds Disease into Adulthood

Lejla Vajzovic, MD; and Yuxi Zheng, MD

Anesthesia Trends in VR Surgery

Jason Fan, MD; and Krish Kasetty, MD

AI in Clinical Trials: Where We Are Now

Dr. Allingham asks Dr. Jaffe to discuss the role of AI in retina clinical trials and what the future might hold. For one, AI could save time and money when evaluating retinal imaging, according to Dr. Jaffe.

Posted: 5/28/2025


Please log in to leave a comment.

More From Duke AVS 2025 Coverage

Imaging Adult Patients Born Premature

Aleksandra V. Rachitskaya, MD; and Cynthia Toth, MD

Managing PVR: Tips and Tricks

Jason Hsu, MD; and Sharon Fekrat, MD

GLP-1 Receptor Agonists and DR

Majda Hadziahmetovic, MD; and Oleg Alekseev, MD, PHD

Managing MTM and Macular Holes

Gavin Tan, MD, PhD, FRCSed; and Krish Kasetty, MD